MediCity Nottingham based Locate Therapeutics Ltd is the first firm to receive equity finance investment from the Midlands Engine Investment Fund (MEIF) MEIF is providing £400k as part of a £2million investment that will help the firm to deliver an innovative targeted drugs and...
Nottingham-based drug discovery company XenoGesis is set to move into BioCity Nottingham’s new Discovery Building, after receiving grant funding from the Government’s Regional Growth Fund and the University of Derby Invest to Grow Programme. XenoGesis will be taking 5,500 sq ft on the first floor of...
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK. Clients from across the globe will be able to access highly experienced teams specialising in these core drug discovery disciplines. Both...
Marketing agency, V Formation has launched a series of workshops aimed at junior marketers looking to get to grips with the key elements of marketing. The series, entitled ‘Marketing – the nuts & bolts’, comprises four practical workshops that cover the key marketing fundamentals of marketing...
Two Nottinghamshire companies are celebrating success following the prestigious Medilink UK Healthcare Business awards, which took place on Wednesday 25th April 2018. The awards recognised a multitude of achievements and outstanding contributions to the Life Sciences, and seven companies from across the country were crowned as...
Are you an innovator with a scaling business and looking for investment to further scale and grow your business in the UK or Internationally? Are you a business adding value to your customers, market or sector? UKBAA is looking for scaling businesses that are on...
Aurelia Bioscience welcomes Payash Bahuguna as their new Marketing Manager. Aurelia Bioscience is a UK-based CRO offering expertise in customised bioassay development, pharmacological profiling and compound screening to the pharma, SME and biotech sector. It specialises in developing robust, reproducible and physiologically relevant bioassays that are...
AdamsonJones, a firm of patent and trade mark attorneys, has helped more Nottinghamshire companies protect their inventions overseas through the World Intellectual Property Office (WIPO) than any other rival firm of patent attorneys in the county. Statistics from WIPO show that since 2015 AdamsonJones, which has...
Mironid is delighted to announce the appointment of Dr Steve Felstead as Chief Medical Officer (CMO) Dr Felstead retired from the position of Vice President, Head of Clinical Research, Pharmatherapeutics Division, Pfizer Inc in April 2014. He joined Pfizer in 1989, having qualified in Medicine at Leeds...